[go: up one dir, main page]

AU2001264936A1 - Haplotypes of the ctla4 gene - Google Patents

Haplotypes of the ctla4 gene

Info

Publication number
AU2001264936A1
AU2001264936A1 AU2001264936A AU6493601A AU2001264936A1 AU 2001264936 A1 AU2001264936 A1 AU 2001264936A1 AU 2001264936 A AU2001264936 A AU 2001264936A AU 6493601 A AU6493601 A AU 6493601A AU 2001264936 A1 AU2001264936 A1 AU 2001264936A1
Authority
AU
Australia
Prior art keywords
haplotypes
ctla4 gene
ctla4
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264936A
Inventor
Anne Chew
Julie Y. Choi
Chad Messer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Publication of AU2001264936A1 publication Critical patent/AU2001264936A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70521—CD28, CD152

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001264936A 2000-05-23 2001-05-23 Haplotypes of the ctla4 gene Abandoned AU2001264936A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20635300P 2000-05-23 2000-05-23
PCT/US2001/016905 WO2001090122A2 (en) 2000-05-23 2001-05-23 Haplotypes of the ctla4 gene

Publications (1)

Publication Number Publication Date
AU2001264936A1 true AU2001264936A1 (en) 2001-12-03

Family

ID=22765983

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264936A Abandoned AU2001264936A1 (en) 2000-05-23 2001-05-23 Haplotypes of the ctla4 gene

Country Status (2)

Country Link
AU (1) AU2001264936A1 (en)
WO (1) WO2001090122A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887471B1 (en) 1991-06-27 2005-05-03 Bristol-Myers Squibb Company Method to inhibit T cell interactions with soluble B7
US7094874B2 (en) 2000-05-26 2006-08-22 Bristol-Myers Squibb Co. Soluble CTLA4 mutant molecules
US20040022787A1 (en) 2000-07-03 2004-02-05 Robert Cohen Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID
CZ303959B6 (en) 2000-07-03 2013-07-17 Bristol-Myers Squibb Company Soluble CTLA4 molecules, pharmaceutical composition containing thereof and use of the molecules
JP2004523244A (en) * 2001-03-19 2004-08-05 ケンブリッジ・ユニバーシティ・テクニカル・サービシーズ・リミテッド Disease-related polymorphisms at the CTLA-4 locus
DK1397153T3 (en) 2001-05-23 2008-05-26 Bristol Myers Squibb Co Method for protecting allogeneic islet cell graft using soluble CTLA4 mutant molecules
WO2005014612A1 (en) * 2003-07-09 2005-02-17 The Brigham And Women's Hospital, Inc. Novel splice variant of ctla-4
AU2006311586A1 (en) * 2005-11-08 2007-05-18 Avi Biopharma, Inc. Immunosuppression compound and treatment method
US8501704B2 (en) 2005-11-08 2013-08-06 Sarepta Therapeutics, Inc. Immunosuppression compound and treatment method

Also Published As

Publication number Publication date
WO2001090122A2 (en) 2001-11-29
WO2001090122A3 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
AU2001264936A1 (en) Haplotypes of the ctla4 gene
AU2002211373A1 (en) Haplotypes of the por gene
AU2001255403A1 (en) Haplotypes of the apoe gene
AU2001255397A1 (en) Haplotypes of the ugt1a1 gene
AU2001259595A1 (en) Haplotypes of the crybb1 gene
AU2001286949A1 (en) Haplotypes of the bf gene
AU2001257020A1 (en) Haplotypes of the hsd3b1 gene
AU2001292815A1 (en) Haplotypes of the scya8 gene
AU2001290603A1 (en) Haplotypes of the or11a1 gene
AU2002229099A1 (en) Haplotypes of the prlr gene
AU2001255316A1 (en) Haplotypes of the nat1 gene
AU2001284736A1 (en) Haplotypes of the pla2g1b gene
AU2001249650A1 (en) Haplotypes of the chrnb3 gene
AU2001274995A1 (en) Haplotypes of the rlbp1 gene
AU2001286644A1 (en) Haplotypes of the gng7 gene
AU2002245073A1 (en) Haplotypes of the f2rli gene
AU2002213185A1 (en) Haplotypes of the chrm5 gene
AU2002227177A1 (en) Haplotypes of the scya21 gene
AU2001273117A1 (en) Haplotypes of the appbp1 gene
AU2001294586A1 (en) Haplotypes of the htr5a gene
AU2001253531A1 (en) Haplotypes of the galr1 gene
AU2001286805A1 (en) Haplotypes of the sell gene
AU2002236585A1 (en) Haplotypes of the grm8 gene
AU2001270296A1 (en) Haplotypes of the mc2r gene
AU2002213083A1 (en) Haplotypes of the htatip gene